Peptides

The Wolverine Stack: BPC-157 + TB-500 Protocol for Healing

Medically reviewed by Medical Advisory Board Last reviewed 2026-09-09

Why this combination is the gold standard for injury repair — and exactly how to run it

The Wolverine Stack combines BPC-157 and TB-500 (Thymosin Beta-4) — the two most evidence-backed healing peptides — targeting complementary repair mechanisms. BPC-157 drives local growth factor signaling and tendon repair; TB-500 provides systemic angiogenesis and fibroblast migration. Together they address tissue repair from both ends, which is why this combination dominates the injury recovery peptide space.

The name comes from Wolverine's near-instant healing ability in the X-Men universe, an apt, if aspirational, analogy. In the peptide community, the Wolverine Stack is shorthand for combining BPC-157 and TB-500, the two peptides with the most animal and anecdotal evidence for accelerating tissue repair.

With 5,400 monthly searches and a KD of 15, "wolverine stack" is one of the most underserved high-intent searches in the peptide space. People searching for it already know what they want, they're in research mode and looking for a clear protocol to follow.

Partner · Opt Health

Want peptides prescribed and monitored properly?

If you're considering peptide therapy, the difference between a clinical program and a gray-market vial is supervision. Opt Health prescribes peptides through licensed physicians with baseline labs and follow-up testing.

See Opt Health's peptide program →

Why These Two Peptides Together?

BPC-157 and TB-500 address tissue repair through different, complementary mechanisms:

  • BPC-157 (Body Protective Compound-157) — found naturally in gastric juice, works primarily at the injury site. Key mechanisms: upregulates growth factor receptors (VEGF, EGF, GH receptor), promotes tendon-to-bone healing via tendon fibroblast activation, heals gut lining (tight junction proteins), and has anti-inflammatory effects via nitric oxide modulation. Best evidence: tendon, ligament, gut, and peripheral nerve repair.
  • TB-500 (Thymosin Beta-4)** — a naturally occurring peptide in the thymus, works systemically. Key mechanisms: promotes angiogenesis (new blood vessel formation to supply oxygen to healing tissue), stimulates fibroblast and endothelial cell migration, actin regulation that enables cell motility needed for repair. Best evidence: cardiac tissue, skeletal muscle, and systemic wound healing.

The combination works because healing requires both: local repair signaling (BPC-157's domain) and systemic vascular supply to the injury site (TB-500's domain). Neither alone addresses both requirements as effectively as the combination.

Full Protocol

BPC-157TB-500
Dose250–350 mcg2–2.5 mg
FrequencyDaily2× per week (loading); 1× per week (maintenance)
Duration4–12 weeks4–6 weeks loading, then maintenance as needed
Injection siteSubcutaneous near injury when possible; or systemic SubQSubcutaneous — any site (works systemically)
Route alternativeOral (500 mcg) for gut-specific healingInjectable only for systemic effect

Can you inject them together? Yes — both can be drawn into the same syringe and injected at the same site. Many users combine them for convenience. Reconstitute each separately, then draw into the same insulin syringe before injecting.

Loading vs. maintenance for TB-500: Run 2× weekly for the first 4–6 weeks (loading phase to build systemic levels), then drop to 1× weekly maintenance. BPC-157 is run daily throughout.

Injection Sites by Injury, Nasal Spray, and Storage

For BPC-157, a near-injury injection means using accessible subcutaneous tissue in the same region. TB-500 can be injected at any subcutaneous site because it works systemically.

  • Knee: Use subcutaneous tissue around the knee instead of the abdomen, while avoiding the joint itself.
  • Shoulder: Use accessible subcutaneous tissue near the affected shoulder.
  • Tennis elbow: Use subcutaneous tissue near the lateral elbow, which is the outer side associated with the lateral epicondyle.
  • Back or lower back: Use abdominal or flank subcutaneous tissue near the affected region. Direct self-injection into the lower back is impractical because that area has little accessible subcutaneous tissue.

Subcutaneous injections reach systemic circulation from essentially any suitable subcutaneous site. Controlled research has not established near-injury injection as a requirement or shown that it produces better outcomes for BPC-157. It is a common practice and convenience convention. The exact injection site is even less important for TB-500 because the peptide works systemically.

Some suppliers sell nasal-spray peptide products as an alternative delivery route. The BPC-157 and TB-500 doses in the Full Protocol table apply to subcutaneous injections. The sources used for this page do not establish nasal bioavailability or dose equivalence for either peptide, so an injectable dose cannot be converted into a nasal dose from the available data.

For storage after reconstitution, keep reconstituted peptides refrigerated and do not freeze them. Use the reconstitution guide for specific stability and storage-duration guidance instead of applying a single timeframe to every preparation.

What Injuries Respond Best

  • Tendon and ligament injuries: This is where the evidence is strongest. Animal studies show BPC-157 significantly accelerates tendon-to-bone healing. Anecdotal reports in the fitness community for chronic tendinopathy (patellar, Achilles, rotator cuff) are consistently positive.
  • Muscle tears: Both peptides support muscle repair — BPC-157 via growth factor upregulation, TB-500 via fibroblast migration and angiogenesis. Users report faster recovery from partial muscle tears.
  • Joint injuries: Anti-inflammatory effects of BPC-157 plus angiogenic effects of TB-500 benefit joint healing, though cartilage repair (as opposed to surrounding tissue) is less well-supported.
  • Gut healing: BPC-157 specifically — oral dosing for leaky gut, IBD, and gastric ulcers. TB-500 adds little for gut-specific healing.
  • Nerve injuries: BPC-157 has the most evidence for peripheral nerve repair acceleration — worth noting for anyone with nerve damage from injury.

Access and Legal Status in 2026

Both peptides have been through significant regulatory shifts — and the landscape is changing again:

  • BPC-157: Added to the FDA's 503A difficult-to-compound list in 2024, which blocked traditional US compounding pharmacies from producing it. However, in July 2026, the FDA Pharmacy Compounding Advisory Committee voted to recommend that BPC-157 be returned to compounding eligibility. The FDA's final decision is pending.
  • TB-500: Also reviewed by the July 2026 committee and recommended for compounding access. TB-500 was less affected by the 2024 restrictions than BPC-157 but still faced supply uncertainty.
  • What this means for the Wolverine Stack: If the FDA accepts the committee's recommendation, both peptides could once again be available through licensed compounding pharmacies with a prescription — potentially restoring the most straightforward legal access pathway for this combination. See our peptide therapy cost guide for expected pricing.
  • Current status: Until the FDA's final decision, both peptides remain available primarily as research chemicals. If BPC-157 access is still restricted when you read this, see our BPC-157 alternatives for compounds with similar healing properties. Both are WADA-prohibited for competitive athletes.

Frequently Asked Questions

Why is it called the Wolverine Stack?

The name references Wolverine (the Marvel/X-Men character) whose mutant ability is near-instant healing from any injury. The BPC-157 + TB-500 combination became known as the Wolverine Stack in fitness and biohacking communities because of its reputation as the most effective peptide combination for accelerating injury recovery — aspirationally mimicking Wolverine's regenerative capacity.

Can I use BPC-157 and TB-500 at the same time?

Yes. They can be injected simultaneously in the same syringe, or separately at different sites. The mechanisms are complementary and don't interfere. Most users combine them in one injection for convenience. Draw each from its reconstituted vial into the same insulin syringe and inject at a single SubQ site.

How long does the Wolverine Stack take to work?

Most users report noticeable improvement in pain and mobility within 2–4 weeks. More significant structural healing (tendons, ligaments) takes 6–12 weeks — consistent with normal connective tissue repair timelines, which the peptides appear to accelerate rather than bypass. Don't expect overnight results; expect a meaningful improvement in healing trajectory.

Do I need both BPC-157 and TB-500, or just one?

For acute injury recovery, the combination outperforms either alone — the complementary mechanisms address both local repair signaling (BPC-157) and systemic vascular support (TB-500). For gut healing specifically, BPC-157 alone (orally) is the appropriate choice; TB-500 doesn't add much for gut-specific issues. For general tissue maintenance without a specific injury, BPC-157 alone is the more cost-effective starting point.

Topic updates

Get the weekly peptide roundup

Peptide therapy, GLP-1s, growth hormone peptides, healing peptides, safety notes, and comparison guides.

No spam. Unsubscribe anytime.

Want peptide therapy handled by a physician who works from your labs? See how Opt Health does it →

Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before making changes to your health regimen.

Check Where You Stand

Take our free health assessment to understand your metabolic, hormonal, and recovery risk factors — and get personalized recommendations.

Take the Free Assessment →

Free · Takes 5 minutes · Instant results

Related Reading

← Back to Peptide Therapy